Genentech, Inc.

Verified Pharmaceutical Manufacturer & Oncology Drug Supplier

Back to Pharmaceuticals Directory

Genentech, Inc.

Verified Partner

Registered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.

Company Profile & Registration

Legal Organization NameGenentech, Inc.

Manufacturer Identification CodeRegistered

Authorized RepresentativeCorporate Representative

Compliance & StatusActive / Listed

Oncology Drugs & Clinical Formulations

Featured Drug Formulation

Tecentriq

Generic: atezolizumab

Class: Immune Checkpoint Inhibitor (PD-1 / PD-L1 / CTLA-4)

View Complete Drug Profile

Indications: Locally advanced or metastatic urothelial carcinoma, non-small cell lung cancer, extensive-stage small cell lung cancer (ES-SCLC), and unresectable hepatocellular carcinoma in combination with bevacizumab.

Direct Communication & Assistance

Send an Inquiry to Genentech, Inc.

Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.